-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE RECEIVES YALE IRB APPROVAL, ENABLING PATIENT RECRUITMENT FOR PARTS B AND C OF CMND-100 PHASE I/II TRIAL, FOLLOWING POSITIVE SAFETY RESULTS

路透·09/08/2026 11:42:00

登录查看新闻详情